Hope Women's Cancer Centers-Asheville is a clinical research site located in Asheville, North Carolina, United States 28816.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Hope Women's Cancer Centers-Asheville has participated in 47 clinical trials with 21 currently active.
Therapeutic areas: Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.
Sponsors: National Cancer Institute (NCI), Wake Forest University Health Sciences, University of Rochester NCORP Research Base.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Hope Women's Cancer Centers-Asheville has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hope Women's Cancer Centers-Asheville has 47 clinical trials on record, with 21 currently active. Their work covers Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.
Yes — Hope Women's Cancer Centers-Asheville holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.